EdgarLookup

LIBERTY STAR URANIUM & METALS CORP. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that LIBERTY STAR URANIUM & METALS CORP. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
4248.2%
Return on Assets
Net income ÷ assets
-1.03x
Debt-to-Equity
Total liabilities ÷ equity

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2015 Jan 31, 2015 $0 May 1, 2015
FY2015 Jan 31, 2014 $0 May 1, 2015
FY2013 Jan 31, 2013 $0 May 16, 2014
FY2012 Jan 31, 2012 $0 May 16, 2013
FY2011 Jan 31, 2011 $0 Apr 30, 2012

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2025 $2.12M May 1, 2025
FY2025 Jan 31, 2024 ($4.08M) May 1, 2025
FY2024 Jan 31, 2023 $565.6K May 15, 2024
FY2023 Jan 31, 2022 ($438.7K) May 16, 2023
FY2022 Jan 31, 2021 ($749.7K) May 17, 2022
FY2021 Jan 31, 2020 ($337.5K) May 3, 2021
FY2020 Jan 31, 2019 ($1.31M) Apr 30, 2020
FY2019 Jan 31, 2018 ($992.8K) May 16, 2019
FY2018 Jan 31, 2017 ($1.50M) May 16, 2018
FY2017 Jan 31, 2016 ($1.57M) May 1, 2017

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2025 ($1.70M) May 1, 2025
FY2025 Jan 31, 2024 ($1.54M) May 1, 2025
FY2024 Jan 31, 2023 ($831.1K) May 15, 2024
FY2023 Jan 31, 2022 ($517.8K) May 16, 2023
FY2022 Jan 31, 2021 ($594.9K) May 17, 2022
FY2021 Jan 31, 2020 ($467.8K) May 3, 2021
FY2020 Jan 31, 2019 ($777.1K) Apr 30, 2020
FY2019 Jan 31, 2018 ($699.5K) May 16, 2019
FY2018 Jan 31, 2017 ($882.7K) May 16, 2018
FY2017 Jan 31, 2016 ($863.0K) May 1, 2017

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2025 ($1.02M) May 1, 2025
FY2025 Jan 31, 2024 ($1.39M) May 1, 2025
FY2024 Jan 31, 2023 ($540.6K) May 15, 2024
FY2023 Jan 31, 2022 ($511.4K) May 16, 2023
FY2022 Jan 31, 2021 ($380.9K) May 17, 2022
FY2021 Jan 31, 2020 ($334.4K) May 3, 2021
FY2020 Jan 31, 2019 ($359.9K) Apr 30, 2020
FY2019 Jan 31, 2018 ($650.2K) May 16, 2019
FY2018 Jan 31, 2017 ($505.9K) May 16, 2018
FY2017 Jan 31, 2016 ($550.6K) May 1, 2017

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2021 Jan 31, 2021 $500 May 3, 2021
FY2020 Jan 31, 2020 $500 Apr 30, 2020
FY2019 Jan 31, 2019 $500 May 16, 2019
FY2018 Jan 31, 2018 $500 May 16, 2018

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2025 $50.0K May 1, 2025
FY2025 Jan 31, 2024 $104.1K May 1, 2025
FY2024 Jan 31, 2023 $61.0K May 15, 2024
FY2023 Jan 31, 2022 $143.5K May 16, 2023
FY2022 Jan 31, 2021 $45.1K May 17, 2022
FY2021 Jan 31, 2020 $73.2K May 3, 2021
FY2020 Jan 31, 2019 $9.7K Apr 30, 2020
FY2019 Jan 31, 2018 $54.4K May 16, 2019
FY2018 Jan 31, 2017 $17.2K May 16, 2018
FY2017 Jan 31, 2016 $92.9K May 1, 2017

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2025 $1.72M May 1, 2025
FY2025 Jan 31, 2024 $3.17M May 1, 2025
FY2024 Jan 31, 2023 $640.3K May 15, 2024
FY2023 Jan 31, 2022 $1.61M May 16, 2023
FY2022 Jan 31, 2021 $2.06M May 17, 2022
FY2021 Jan 31, 2020 $1.78M May 3, 2021
FY2020 Jan 31, 2019 $1.70M Apr 30, 2020
FY2019 Jan 31, 2018 $1.55M May 16, 2019
FY2018 Jan 31, 2017 $1.12M May 16, 2018
FY2017 Jan 31, 2016 $1.07M May 1, 2017

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2025 ($1.67M) May 1, 2025
FY2025 Jan 31, 2024 ($3.06M) May 1, 2025
FY2025 Jan 31, 2023 ($579.3K) May 1, 2025
FY2024 Jan 31, 2022 ($1.47M) May 15, 2024
FY2023 Jan 31, 2021 ($2.01M) May 16, 2023
FY2022 Jan 31, 2020 ($1.71M) May 17, 2022
FY2021 Jan 31, 2019 ($1.69M) May 3, 2021
FY2020 Jan 31, 2018 ($1.49M) Apr 30, 2020
FY2019 Jan 31, 2017 ($1.10M) May 16, 2019
FY2018 Jan 31, 2016 ($980.2K) May 16, 2018

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2025 ($59.36M) May 1, 2025
FY2025 Jan 31, 2024 ($61.48M) May 1, 2025
FY2024 Jan 31, 2023 ($57.40M) May 15, 2024
FY2023 Jan 31, 2022 ($57.97M) May 16, 2023
FY2022 Jan 31, 2021 ($57.53M) May 17, 2022
FY2021 Jan 31, 2020 ($56.78M) May 3, 2021
FY2020 Jan 31, 2019 ($56.44M) Apr 30, 2020
FY2019 Jan 31, 2018 ($55.14M) May 16, 2019
FY2018 Jan 31, 2017 ($54.14M) May 16, 2018
FY2017 Jan 31, 2016 ($52.65M) May 1, 2017

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2025 $21.0K May 1, 2025
FY2025 Jan 31, 2024 $72.1K May 1, 2025
FY2024 Jan 31, 2023 $32.6K May 15, 2024
FY2023 Jan 31, 2022 $102.7K May 16, 2023
FY2022 Jan 31, 2021 $6.7K May 17, 2022
FY2021 Jan 31, 2020 $25.0K May 3, 2021
FY2020 Jan 31, 2019 $890 Apr 30, 2020
FY2019 Jan 31, 2018 $36.1K May 16, 2019
FY2019 Jan 31, 2017 $5.0K May 16, 2019
FY2018 Jan 31, 2016 $536 May 16, 2018

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2025 0 May 1, 2025
FY2025 Jan 31, 2024 0 May 1, 2025
FY2024 Jan 31, 2023 0 May 15, 2024
FY2023 Jan 31, 2022 0 May 16, 2023
FY2022 Jan 31, 2021 0 May 17, 2022
FY2017 Jan 31, 2017 0 May 1, 2017
FY2017 Jan 31, 2016 0 May 1, 2017
FY2016 Jan 31, 2015 0 May 17, 2016
FY2015 Jan 31, 2014 0 May 1, 2015

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2025 0 May 1, 2025
FY2025 Jan 31, 2024 0 May 1, 2025
FY2024 Jan 31, 2023 0 May 15, 2024
FY2023 Jan 31, 2022 0 May 16, 2023
FY2017 Jan 31, 2017 0 May 1, 2017
FY2017 Jan 31, 2016 0 May 1, 2017
FY2016 Jan 31, 2015 0 May 17, 2016
FY2015 Jan 31, 2014 0 May 1, 2015
FY2013 Jan 31, 2013 0 May 16, 2014
FY2012 Jan 31, 2012 0 May 16, 2013

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2025 53.33M May 1, 2025
FY2025 Oct 31, 2024 53.33M May 1, 2025
FY2025 Jan 31, 2024 49.81M May 1, 2025
FY2024 Jan 31, 2023 18.67M May 15, 2024
FY2023 Jan 31, 2022 13.46M May 16, 2023
FY2025 Oct 31, 2021 10.89M May 1, 2025
FY2022 Jan 31, 2021 9.90M May 17, 2022
FY2021 Jan 31, 2020 9.12M May 3, 2021
FY2020 Jan 31, 2019 4.10B Apr 30, 2020
FY2019 Jan 31, 2018 2.45B May 16, 2019